FORM 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Delaware 47-1758322 108 Wilmot Road, Deerfield, Illinois 60015 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended May 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q3 2024 Earnings Conference Call June 27, 2024 8:30 AM ET Company Participants Tiffany Kanaga - VP of IR Tim Wentworth - CEO Manmohan Mahajan - Global Chief Financial Officer Mary Langowski - President, U.S. Healthcare Rick Gates - SVP and Walgreens Chief Pharmacy Officer Tracey Brown - President, Walgreens' Retail and Chief Customer Officer Conference Call Participants Lisa Gill - JPMorgan Charles Rhyee - TD Cowen Eric Percher - Nephron Research Ann Hynes - Mizuh ...

Update on strategic review Exhibit 99.1 Walgreens Boots Alliance Reports Fiscal 2024 Third Quarter Results Lowering Guidance in Continued Challenging Environment; Provides Strategic Update Third quarter financial highlights Fiscal 2024 guidance 1 • Lowering fiscal 2024 adjusted EPS** guidance to $2.80 to $2.95 reflecting challenging pharmacy industry trends and a worse-than- expected U.S. consumer environment DEERFIELD, Ill. — June 27, 2024 — Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced fina ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended February 29, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From _______to _______ Commission File Number 001-36759 WALGREENS BOOTS ALLIANCE, INC. (Exact name of registrant as specified in its charter) (State or Other Juris ...

Second Quarter Fiscal 2024 Results March 28, 2024 © 2024 Walgreens Boots Alliance, Inc. All rights reserved. Safe Harbor and Non-GAAP Cautionary Note Regarding Forward-Looking Statements: All statements in this presentation that are not historical are forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include, without limitation, estimates of and goals for future operating, financial and tax performance and results, including ...

Exhibit 99.1 Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results Second quarter operational results in line with expectations, U.S. Healthcare achieved adjusted EBITDA profitability, narrowing full-year adjusted EPS guidance range Second quarter financial highlights • Second quarter loss per share* was $6.85 compared to earnings per share of $0.81 in the year-ago quarter; Second quarter results included a $5.8 billion after-tax non-cash impairment charge related to VillageMD goodwill • Adjus ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q1 2024 Earnings Conference Call January 4, 2024 8:30 AM ET Company Participants Tiffany Kanaga - Vice President, Global Investor Relations Tim Wentworth - Chief Executive Officer Manmohan Mahajan - Interim Global Chief Financial Officer John Driscoll - President of US Healthcare Rick Gates - Senior Vice President and Chief Pharmacy Officer Conference Call Participants Lisa Gill - JPMorgan George Hill - Deutsche Bank Charles Rhyee - TD Cowen Eric Percher - Nephron ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended November 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From _______to _______ Commission File Number 001-36759 WALGREENS BOOTS ALLIANCE, INC. (Exact name of registrant as specified in its charter) (State or Other Juris ...

Fourth Quarter and Fiscal 2023 Results October 12, 2023 ...

| --- | --- | |---------------------------------------------------|----------------------------------------------| | (Exact name of registrant as \nDelaware | specified in its charter) \n47-1758322 | | (State of incorporation) | (I.R.S. Employer Identification No.) | | 108 Wilmot Road, Deerfield, Illinois | 60015 | | --- | --- | --- | |-----------------------------------------------------------------------------------|-------------------|-------------------------------------------| | Securities registered p ...